Table 2.
|
|
Thyroid autoantibodies |
|||
---|---|---|---|---|---|
Sex, age (years) | Status | TBAb | TSAb | TgAb | TPOAb |
F, 23 | Hypo | 3202 | 802 | ||
Hyper | Neg | 1900 | 6402 | 3202 | |
Eu | Neg | 100 | 802 | Neg | |
F, 53 | Hypo | 6402 | 3202 | ||
Hyper | Neg | 780 | 6402 | 3202 | |
Eu | Neg | 96 | 1602 | 802 | |
Hyper | Neg | 1050 | 6402 | 3202 | |
Eu | Neg | 100 | 1602 | 802 | |
F, 28 | Hypo | (80) | (160) | ||
Hyper | Neg | (900) | 6402 | 1602 | |
F, 42 | Hypo | pos | pos | ||
Hyper | 802 | 1602 | |||
F, 38 | Hypo | 6402 | 6402 | ||
Hyper | Neg | 12802 | 12802 | ||
F, 80 | Neg | 1583a | 1300 units |
First five patients from Ref. (31); sixth patient from Ref. (34). Values for all thyroid autoantibodies are TSAb μU/mL bovine thyrotropin (bTSH) equivalent; Neg, negative (undetectable); blanks, data not reported. TgAb and TPOAb are reciprocal titers. Bold indicates positive values for TSAb or TBAb, or increased values for TgAb or TPOAb after LT4. Parentheses indicate values estimated from the figures in Ref. (31) for TgAb, TPOAb, or TSAb activity.
% Stimulation of cAMP.